The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Cell-based Biological Reagents Market In 2026 And How Much Will It Reach By 2030?

The cell-based biological reagents market size has experienced robust growth in recent years. It is projected to expand from $13.78 billion in 2025 to $14.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. The historical expansion can be attributed to factors such as increased drug discovery research activities, higher spending on pharmaceutical R&D, a growing reliance on cell-based assays for toxicity testing, advancements in cell culture technologies, and the rising adoption of standardized biological reagents.

The cell-based biological reagents market is anticipated to show significant expansion in the next few years. It is projected to achieve a size of $20.74 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period can be attributed to factors such as increasing demand for predictive in vitro models, the expansion of personalized medicine research, a rising adoption of AI-driven drug screening, increasing investments in regenerative medicine studies, and a greater focus on complex disease modeling. Prominent trends for the forecast period include the increasing uptake of 3D cell culture and assay platforms, a rise in the use of gene-edited and reporter cell lines, growing demand for high-throughput cell-based screening, the broadening of stem cell and primary cell applications, and an enhanced focus on developing physiologically relevant models.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33059&type=smp

What Major Growth Factors Are Impacting The Cell-based Biological Reagents Market?

The heightened emphasis on cell and gene therapies is projected to fuel the expansion of the cell-based biological reagents market. These therapies utilize living cells or genetic elements to repair, replace, or modify impaired cells or genes, aiming to treat or cure various diseases. The adoption of cell and gene therapies is increasing primarily due to the growing occurrence of rare and genetic illnesses, as they can address the fundamental issues at a cellular or genetic level, potentially offering remedies instead of just symptom management provided by traditional treatments. Cell-based biological reagents facilitate cell and gene therapies by delivering the essential tools and substances required for cultivating, modifying, and efficiently delivering therapeutic cells or genetic material. A relevant example shows that in March 2024, IQVIA Holdings Inc., a US-based healthcare company focused on clinical research services and analytics, revealed global expenditure on cell and gene therapies soared to $5.9 billion in 2023, marking an increase of 38% from 2022. Hence, the increasing concentration on cell and gene therapies is stimulating the growth of the cell-based biological reagents market.

What Segment Types Are Included In The Cell-based Biological Reagents Market Analysis?

The cell-based biological reagents market covered in this report is segmented –

1) By Product Type: Assay Kits; Cell Lines; Reagents; Other Product Types

2) By Technology: Two Dimensional Cell Culture; Three Dimensional Cell Culture; High Throughput Screening Platforms; Stem Cell Technologies; Gene Edited Cell Platforms

3) By Application: Drug Discovery And Development; Toxicology And Safety Assessment; Disease Modeling; Regenerative Medicine; Basic Research

4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Clinical And Diagnostic Laboratories; Government And Public Health Agencies

Subsegments:

1) By Assay Kits: Cell Viability Assay Kits; Cytotoxicity Assay Kits; Proliferation Assay Kits; Apoptosis Assay Kits; Signal Transduction Assay Kits

2) By Cell Lines: Primary Cell Lines; Immortalized Cell Lines; Stem Cell Lines; Cancer Cell Lines; Transfected Cell Lines

3) By Reagents: Culture Media Reagents; Growth Factor Reagents; Enzyme Reagents; Supplement Reagents; Antibody Reagents

4) By Other Product Types: Cryopreservation Reagents; Labware Consumables; Transfection Reagents; Cell Sorting Reagents; Custom Reagents

Which Trends Are Supporting The Evolution Of The Cell-based Biological Reagents Market?

Leading companies operating in the cell-based biological reagents market are strategically focusing on developing human-induced pluripotent stem cell (iPSC) research products to drive progress in drug discovery, disease modeling, and regenerative medicine applications. Human-induced pluripotent stem cell (iPSC) research products represent comprehensive tools and integrated workflows that allow for the generation, maintenance, differentiation, and analysis of iPSCs, applicable across various areas of biomedical research, including drug testing, disease modeling, and the advancement of cell therapy. For example, in July 2024, BioServe Biotechnologies (India) Private Limited, an India-based biotechnology company, introduced a sophisticated stem cell product line designed to further regenerative medicine and drug development research. This innovation supports biotech research by ensuring reliable iPSC generation, 3D organoid cultures, and precise differentiation tools, which helps to minimize experimental inconsistencies. The products streamline drug discovery by providing human-specific models that reduce reliance on animal testing and accelerate toxicity assessments, contributing to faster therapy development. Ultimately, they empower personalized medicine, facilitating tissue regeneration for conditions such as diabetes or heart failure while simultaneously reducing costs and the likelihood of rejection.

Who Are The Prominent Players Across The Cell-based Biological Reagents Market?

Major companies operating in the cell-based biological reagents market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Corp., Danaher Corporation, GE Healthcare, Becton, Dickinson And Company, Corning Incorporated, Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Abcam plc, Promega Corporation, Takara Bio Inc., R&D Systems Inc., MP Biomedicals, Sino Biological, Cell Signaling Technology Inc., InvivoGen, Tocris Bioscience, and OPM Biosciences.

Access The Complete Cell-based Biological Reagents Market Report:

https://www.thebusinessresearchcompany.com/report/cell-based-biological-reagents-market-report

Which Region Is The Primary Market For The Cell-based Biological Reagents Market?

North America was the largest region in the cell-based biological reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-based biological reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cell-based Biological Reagents Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model